Influenza and atherosclerosis: vaccination for cardiovascular disease prevention

Bibliography

• American Heart Association. Heart Disease and Stroke Statistics -2003 Update. American Heart Association (2002).
   Google Scholar
• REDDY KS: Cardiovascular disease in non-Western countries. N Engl J. Med. (2004) 350(24):2438–2440.
   PubMed Web of Science ®Google Scholar
• OSLER W: Lectures on angina pectoris and allied states (1897). In: William Osler's Collected Papers on the Cardiovascular System. Fye BF (Ed.), Adams, LB, New York, USA (1985):239–257.
   Google Scholar
• STALLONES RA: The rise and fall of ischemic heart disease. Sci. Am. (1980) 243(5):53–59.
   PubMed Web of Science ®Google Scholar
• LIBBY P: Inflammation in atherosclerosis. Nature (2002) 420(6917):868–874.
   PubMed Web of Science ®Google Scholar
• MADJID M, ZARRABI A. LITOVSKY S, WILLERSON JT, CASSCELLS W: Finding vulnerable atherosclerotic plaques. Is it worth the effort? Arterioscler. Thromb. Vasc. Biol (2004) 24(10):1775–1782.
   PubMed Web of Science ®Google Scholar
• ARCIERO TJ, JACOBSEN SJ, REEDER GS et al.: Temporal trends in the incidence of coronary disease. Am. J. Med. (2004) 117(4):228–233.
   PubMed Web of Science ®Google Scholar
• ERGIN A. MUNTNER P, SHERWIN R, HE J: Secular trends in cardiovascular disease mortality, incidence, and case fatality rates in adults in the United States. Am. J. Med. (2004) 117(4):219–227.
   PubMed Web of Science ®Google Scholar
• ZHOU X, HANSSON GK: Immunomodulation and vaccination for atherosclerosis. Expert Opin. Biol Ther. (2004) 4(4):599–612.
   PubMed Web of Science ®Google Scholar
• WICK G, KNOFLACH M, XU Q: Autoimmune and inflammatory mechanisms in atherosclerosis. Annu. Rev Immunol (2004) 22:361–403.
   PubMed Web of Science ®Google Scholar
• MATSUURA E, LOPEZ LR: Are oxidized LDL/beta2-glycoprotein I complexes pathogenic antigens in autoimmune-mediated atherosclerosis? Clin. Dev. Immunol (2004) 11(2):103–111.
   Google Scholar
• MATSUURA E, KOBAYASHIA K, KOIKEB T et al.: Atherogenic autoantigen: oxidized LDL complexes with beta2- glycoprotein I. Immunobiology (2003) 207(1):17–22.
   PubMed Web of Science ®Google Scholar
• FREDRIKSON GN, SODERBERG I, LINDHOLM M et al.: Inhibition of atherosclerosis in apoE-null mice by immunization with apoB-100 peptide sequences. Arterioscler. Thromb. Vasc. Biol. (2003) 23(5):879–884.
   PubMed Web of Science ®Google Scholar
• HANSSON GK: The B cell: a good guy invascular disease? Arterioscler. Thromb. Vasc. Biol. (2002) 22(4):523–524.
   PubMed Web of Science ®Google Scholar
• MADJID M, NAGHAVI M, LITOVSKY S, CASSCELLS SW: Influenza and cardiovascular disease: a new opportunity for prevention and the need for further studies. Circulation (2003) 108:2730–2736.
   PubMed Web of Science ®Google Scholar
• MADJID M, ABOSHADY I, AWAN I, LITOVSKY S, CASSCELLS SW: Influenza and cardiovascular disease: Is there a causal relationship? Tex. Heart Inst. J. (2004) 31:4–13.
   PubMed Web of Science ®Google Scholar
• HIGUCHI ML, SAMBIASE N, PALOMINO S et al.: Detection of Mycoplasma pneumoniae and Chlamydia pneumoniae in ruptured atherosclerotic plaques. Bra. z J. Med. Biol. Res. (2000) 33(9):1023–1026.
   PubMed Web of Science ®Google Scholar
• HARASZTHY VI, ZAMBON JJ, TREVISAN M, ZEID M, GENCO RJ: Identification of periodontal pathogens in atheromatous plaques. J. Periodontol (2000) 71(10):1554–1560.
   PubMed Web of Science ®Google Scholar
• ALBER DG, POWELL KL, VALLANCE P, GOODWIN DA, GRAHAME-CLARKE C: Herpesvirus infection accelerates atherosclerosis in the apolipoprotein E-deficient mouse. Circulation (2000) 102(7):779–785.
   PubMed Web of Science ®Google Scholar
• EPSTEIN SE, ZHOU YF, ZHU J: Infection and atherosclerosis: emerging mechanistic paradigms. Circulation (1999) 100(4):e20–e28.
   PubMed Web of Science ®Google Scholar
• BURCH GE, HARB JM, HIRAMOTO Y, SHEWEY L: Viral infection of the aorta of man associated with early atherosclerotic changes. Am. Heart J. (1973) 86(4):523–534.
   PubMed Web of Science ®Google Scholar
• LI L, MESSAS E, BATISTA EL, JR, LEVINE RA, AMAR S: PoIhyromonas gingivahs infection accelerates the progression of atherosclerosis in a heterozygous apolipoprotein E-deficient murine model. Circulation (2002) 105(7):861–867.
   PubMed Web of Science ®Google Scholar
• FABRICANT CG, FABRICANT J, LITRENTA MM, MINICK CR: Virus-induced atherosclerosis. J. Exp. Med. (1978) 148(1):335–340.
   PubMed Web of Science ®Google Scholar
• MUHLESTEIN JB, ANDERSON JL, HAMMOND EH et al.: Infection with Chlamydia pneumoniae accelerates the development of atherosclerosis and treatment with azithromycin prevents it in a rabbit model. Circulation (1998) 97(7):633–636.
   PubMed Web of Science ®Google Scholar
• O'CONNOR CM, DUNNE MW, PFEFFER MA et al.: Azithromycin for the secondary prevention of coronary heart disease events: the WIZARD study: a randomized controlled trial. /AMA (2003) 290(11):1459–1466.
   Google Scholar
• MUHLESTEIN JB, ANDERSON JL, CARLQUIST JF et al.: Randomized secondary prevention trial of azithromycin in patients with coronary artery disease: primary clinical results of the ACADEMIC study. Circulation (2000) 102(15):1755–1760.
   PubMed Web of Science ®Google Scholar
• NAGHAVI M, BARLAS Z, SIADATY S et al.: Association of influenza vaccination and reduced risk of recurrent myocardial infarction. Circulation (2000) 102(25):3039–3045.
   PubMed Web of Science ®Google Scholar
• SISCOVICK DS, RAGHUNATHAN TE, LIN D et al.: Influenza vaccination and the risk of primary cardiac arrest. Am. J. Epidemiol (2000) 152(7):674–677.
   PubMed Web of Science ®Google Scholar
• LAVALLEE P, PERCHAUD V, GAUTIER-BERTRAND M, GRABLI D, AMARENCO P: Association between influenza vaccination and reduced risk of brain infarction. Stroke (2002) 33(2):513–518.
   PubMed Web of Science ®Google Scholar
• JACKSON LA, YU O, HECKBERT SR et al.: Influenza vaccination is not associated with a reduction in the risk of recurrent coronary events. Am. J. Epidemiol (2002) 156(7):634–640.
   PubMed Web of Science ®Google Scholar
• NICHOL KL, NORDIN J, MULLOOLY Jet al.: Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly. N Engl. J. Med. (2003) 348(14):1322–1332.
   Google Scholar
• GURFINKEL EP, DE LA FUENTE RL, MENDIZ O, MAUTNER B: Influenza vaccine pilot study in acute coronary syndromes and planned percutaneous coronary interventions: the FLU Vaccination Acute Coronary Syndromes (FLUVACS) Study. Circulation (2002) 105(18):2143–2147.
   PubMed Web of Science ®Google Scholar
• GURFINKEL EP, LEON DE LA FUENTE R, MENDIZ O, MAUTNER B: Flu vaccination in acute coronary syndromes and planned percutaneous coronary interventions (FLUVACS) study: one-year follow-up. Eur. Heart J. (2004) 25(1):25–31.
   PubMed Web of Science ®Google Scholar
• MEYERS DG, BEAHMA D, JURISICHA P, MILFORDC C, EDLAVICHD S: Influenza and pneumococcal vaccinations fail to prevent myocardial infarction. HeartDrug (2004) 4(2):96–100.
   Google Scholar
• ARMSTRONG BG, MANGTANI P, FLETCHER A et al.: Effect of influenza vaccination on excess deaths occurring during periods of high circulation of influenza: cohort study in elderly people. Br. Med. J. (2004) 329(7467):660.
   PubMed Web of Science ®Google Scholar
• DAVIES MJ: The composition of coronary-artery plaques. N Engl. J. Med. (1997) 336(18):1312–1314.
   PubMed Web of Science ®Google Scholar
• FALK E, SHAH PK, FUSTER V: Coronary plaque disruption. Circulation (1995) 92(3):657–671.
   PubMed Web of Science ®Google Scholar
• SHAH PK: Mechanisms of plaque vulnerability and rupture. J. Am. Coll. Cardiol. (2003) 41(4 Suppl. S):155–225.
   Google Scholar
• NAGHAVI M, WYDE P, LITOVSKY S et al.: Influenza infection exerts prominent inflammatory and thrombotic effects on the atherosclerotic plaques of apolipoprotein E-deficient mice. Circulation (2003) 107(5):762–768.
   PubMed Web of Science ®Google Scholar
• BOUWMAN JJ, VISSEREN FL, BOSCH MC, BOUTER KP, DIEPERSLOOT RJ: Procoagulant and inflammatory response of virus-infected monocytes. Eur. J. Clin. Invest. (2002) 32(10):759–766.
   PubMed Web of Science ®Google Scholar
• VISSEREN FL, BOUWMAN JJ, BOUTER KP et al.: Procoagulant activity of endothelial cells after infection with respiratory viruses. Thromb. Haemost. (2000) 84(2):319–324.
   PubMed Web of Science ®Google Scholar
• VAN LENTEN BJ, WAGNER AC, NAYAK DP et al.: High-density lipoprotein loses its anti-inflammatory properties during acute influenza A infection. Circulation (2001) 103(18):2283–2288.
   PubMed Web of Science ®Google Scholar
• VAN LENTEN BJ, WAGNER AC, ANANTHARAIVIAIAH GM et al.: Influenza Infection promotes macrophage traffic into arteries of mice that is prevented by D-4F, an apolipoprotein A-I mimetic peptide. Circulation (2002) 106(9):1127–1132.
   PubMed Web of Science ®Google Scholar
• PLESKOV VM, BANNIKOV AI, ZAITSEV IUV: The receptor-mediated endocytosis of influenza viruses and low-density lipoproteins by tissue cells. Vopr. Virusol (1994) 39(3):121–125.
   PubMed Web of Science ®Google Scholar
• KOL A, LIBBY P: The mechanisms by which infectious agents may contribute to atherosclerosis and its clinical manifestations. Trends Cardiovasc. Med. (1998) 8(5):191–199.
   PubMed Web of Science ®Google Scholar
• BRIDGES CB, FUKUDA K, COX NJ, SINGLETON JA: Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb. Mortal. Wkly Rep. (2001) 50(RR-4):1–44.
   Google Scholar
• PALACHE AM: Influenza vaccines. A reappraisal of their use. Drugs (1997) 54(6):841–856.
   Google Scholar
• MULLOOLY JP, BENNETT MD, HORNBROOK MC et al.: Influenza vaccination programs for elderly persons: cost-effectiveness in a health maintenance organization. Ann. Intern. Med. (1994) 121(12):947–952.
   PubMed Web of Science ®Google Scholar
• NICHOL KL, WUORENMA J, VON STERNBERG T: Benefits of influenza vaccination for low-, intermediate-, and high-risk senior citizens. Arch. Intern. Med. (1998) 158(10:1769–1776.
   PubMed Web of Science ®Google Scholar
• RIDDIOUGH MA, SISK JE, BELL JC:Influenza vaccination. JAMA (1983) 249(23):3189–3195.
   PubMed Web of Science ®Google Scholar
• NICHOL KL, LIND A. MARGOLIS KL et al.: The effectiveness of vaccination against influenza in healthy, working adults. N Engl. J. Med. (1995) 333(14):889–893.
   Google Scholar
• CAMPBELL DS, RUMLEY MH: Cost-effectiveness of the influenza vaccine in a healthy, working-age population. J. Occup. Environ. Med. (1997) 39(5):408–414.
   PubMed Web of Science ®Google Scholar
• BRIDGES CB, THOMPSON WW, MELTZER MI et al.: Effectiveness and cost-benefit of influenza vaccination of healthy working adults: a randomized controlled trial. /AMA (2000) 284(13):1655–1663.
   PubMed Web of Science ®Google Scholar
• MADJID M, LITOVSKY S, VELA D, CASSCELLS SW: Influenza vaccination: An emerging opportunity to prevent cardiovascular disease. Int. Congr. Ser. (2004) 1263:678–681.
   Google Scholar
• GROSS PA, HERMOGENES AW, SACKS HS, LAU J, LEVANDOWSKI RA: The efficacy of influenza vaccine in elderly persons. A meta-analysis and review of the literature. Ann. Intern. Med. (1995) 123(7):518–527.
   PubMed Web of Science ®Google Scholar
• SINGLETON JA, WORTLEY P, LU PJ: Influenza vaccination of persons with cardiovascular disease in the United States. Tex. Heart Inst. J. (2004) 31(1):22–27.
   PubMed Web of Science ®Google Scholar
• AHMED AE, NICHOLSON KG, NGUYEN-VAN-TAM JS: Reduction in mortality associated with influenza vaccine during 1989-90 epidemic. Lancet (1995) 346(8975):591–595.
   PubMed Web of Science ®Google Scholar
• BRIDGES CB, HARPER SA, FUKUDA K et al.: Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm. Rep. (2003) 52(RR-8):1–34.
   Google Scholar
• REICHERT TA, SUGAYA N, FEDSON DS et al.: The Japanese experience with vaccinating schoolchildren against influenza. N Engl. J. Med. (2001) 344(12):889–896. Website
   Google Scholar
• http://reason.com/sullum/061699.shtml SULLUM J: Proceed with caution. Reason Online.
   Google Scholar